XKRX:215380 (Korea, South)  
Woojung Bio Inc logo

Woojung Bio Inc

₩ 4915.00 (-1.5%) Aug 17
P/E:
At Loss
P/B:
2.05
Market Cap:
₩ 62.49B ($ 47.51M)
Enterprise V:
₩ 98.01B ($ 74.51M)
Volume:
32.31K
Avg Vol (2M):
127.06K
Volume:
32.31K
Market Cap ₩:
62.49B
Market Cap $:
47.51M
PE Ratio:
At Loss
Avg Vol (2-Month):
127.06K
Enterprise Value ₩:
98.01B
Enterprise Value $:
74.51M
PB Ratio:
2.05
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Woojung Bio Inc
Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR
Description
Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset 0.3
Debt-to-Equity 1.33
Debt-to-EBITDA 28.05
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.35
Distress
Grey
Safe
Beneish M-Score -2.44
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.6
9-Day RSI 40.78
14-Day RSI 45.15
6-1 Month Momentum % -4.03
12-1 Month Momentum % -30.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.53
Quick Ratio 0.41
Cash Ratio 0.12
Days Inventory 54.95
Days Sales Outstanding 55.52
Days Payable 34.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.3

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₩) 35,409.213
EPS (TTM) (₩) -258
Beta 0.85
Volatility % 23.82
14-Day RSI 45.15
14-Day ATR (₩) 195.022797
20-Day SMA (₩) 5038.25
12-1 Month Momentum % -30.04
52-Week Range (₩) 4300 - 8100
Shares Outstanding (Mil) 12.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Woojung Bio Inc Filings

Document Form Filing Date
No Filing Data